Deep Vein Thrombosis despite Receiving Anticoagulant Prophylaxis; a Cross-sectional Study
Journal of Practical Emergency Medicine,
Vol. 3 No. 3 (2016),
21 September 2016
,
Page 102-98
https://doi.org/10.22037/ijem.v3i3.13714
Abstract
Introduction: Contradicting statistics exist regarding the prevalence of deep vein thrombosis (DVT) following lower limb trauma despite administration of anti-thrombotic agents. The present study aimed to evaluate the prevalence of DVT in patients with lower limb trauma despite receiving anticoagulant prophylaxis. Methods: The present cross-sectional study was carried out to evaluate the prevalence of traumatic lower limbs DVT despite anti-thrombotic therapy, in patients presenting to emergency department. Patients over 18 years old with traumas in the areas lower than knees in need for fixation with cast or splint for > 2 weeks were enrolled. Data were analyzed using SPSS version 21 and descriptive statistics. Results: 130 patients with the mean age of 40.05 ± 18.5 (15-92) were studied (61.5% male). 18 (13.8%) cases had history of drug abuse, 1 (0.8%) had diabetes mellitus, 8 (6.2%) had hypertension, 1 (0.8%) had asthma, and 1 (0.8%) had history of cranial vascular thrombosis. Mechanism of trauma was falling down in 44 (33.8%) cases, road traffic collisions in 50 (38.5%), and direct trauma in 36 (27.7%). 3 (2.3%) patients developed DVT despite receiving prophylactic anti-thrombotic agents. The mean time interval between discharge and development of DVT was 6 ± 3.6 days. Conclusion: Based on the results of the present study, the prevalence of DVT, despite receiving anti-thrombotic agents, in patients with lower limb trauma in need for fixation for > 2 weeks was 2.3%. All three cases of DVT in this study were developed in the first 2 weeks of fixation.- ترومبوز وریدی؛ شکستگی استخوان؛ بی حرکت سازی؛ ضد انعقاد؛ ترومبوآمبولی
How to Cite
References
Cameron M. World Report on Road Traffic Injury Prevention. Injury Prevention. 2004;10(4):255-6.
Manafi RA, Kazemian G, Emami MM, Tavakoli LR, Fallahi A, Nemati A, et al. Deep vein thrombosis following below knee immobilization: the need for chemoprophylaxis. Trauma monthly. 2013;17(4):367.
Chu C-C, Haga H. Venous thromboembolism associated with lower limb fractures after trauma: dilemma and management. Journal of Orthopaedic Science. 2015;20(2):364-72.
Baratloo A, Safari S, Rouhipour A, Hashemi B, Rahmati F, Motamedi M, et al. The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis. Emergency (Tehran, Iran). 2013;2(1):1-11.
Quinlan DJ, McQuillan A, Eikelboom JW. Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary EmbolismA Meta-Analysis of Randomized, Controlled Trials. Annals of internal medicine. 2004;140(3):175-83.
Little MT. Low-Molecular-Weight Heparin Did Not Differ from Placebo in Preventing Clinically Important Deep Venous Thrombosis After Surgical Repair of Leg Fracture. J Bone Joint Surg Am. 2016;98(4):316.
Selby R, Geerts WH, Kreder HJ, Crowther MA, Kaus L, Sealey F. A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures. Journal of orthopaedic trauma. 2015;29(5):224-30.
Long A, Zhang L, Zhang Y, Jiang B, Mao Z, Li H, et al. Efficacy and safety of rivaroxaban versus low-molecular-weight heparin therapy in patients with lower limb fractures. Journal of Thrombosis and Thrombolysis. 2014;38(3):299-305.
Goel D, Buckley R, Abelseth G, Ni A, Gray R. Prophylaxis of deep-vein thrombosis in fractures below the knee a prospective randomised controlled trial. Journal of Bone & Joint Surgery, British Volume. 2009;91(3):388-94.
Arnold JD, Dart BW, Barker DE, Maxwell RA, Burkholder HC, Mejia VA, et al. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients. The American Surgeon. 2010;76(6):563-70.
Jorgensen PS, Warming T, Hansen K, Paltved C, Vibeke Berg H, Jensen R, et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study. Thrombosis research. 2002;105(6):477-80.
Kock HJ, Schmit-Neuerburg KP, Hanke J, Rudofsky G, Hirche H. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet. 1995;346(8973):459-61.
- Abstract Viewed: 726 times
- PDF (فارسی) Downloaded: 916 times
- HTML (فارسی) Downloaded: 110 times
